Literature DB >> 10502004

Posterior fossa medulloblastoma in children and young adults (0-19 years): survival and performance.

E Helseth1, B Due-Tonnessen, F Wesenberg, K Lote, T Lundar.   

Abstract

The objective of this study was to present survival data and outcome status in the long-term survivors of a consecutive series of 111 children and young adults treated for posterior fossa medulloblastoma in our departments from 1960 to 1997. The total surgical mortality was 13%. The surgical mortality rate declined significantly during the time period overall, from 23% before 1970 to 0% after 1990. The 5-year survival rate for patients treated between 1960 and 1973 was 0%, while 5-year survival for patients treated after the introduction of systematic craniospinal radiation in 1974 was 53%. Thirty-four patients were alive at the close of this study, with a mean observation time of 13.5 years. Over half, 61%, of the patients had one or more major deficits/problems with respect to learning ability, power of locomotion, sociability, hobbies and relationships with the opposite sex. A younger age at the time of treatment was correlated with larger deficits/problems in these variables. The correlation between young age at the time of treatment and short final height was significant. The frequency of a second neoplasm was 14%. In all but 3 cases the major cause of permanent deficits/problems was radiation therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10502004     DOI: 10.1007/s003810050437

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  8 in total

1.  Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study.

Authors:  Roger E McLendon; Adesina Adekunle; Veena Rajaram; Mehmet Koçak; Susan M Blaney
Journal:  Arch Pathol Lab Med       Date:  2011-08       Impact factor: 5.534

2.  Deficits in physical function among young childhood cancer survivors.

Authors:  Megan C Hoffman; Daniel A Mulrooney; Julia Steinberger; Jill Lee; K Scott Baker; Kirsten K Ness
Journal:  J Clin Oncol       Date:  2013-06-24       Impact factor: 44.544

3.  Physical performance limitations among adult survivors of childhood brain tumors.

Authors:  Kirsten K Ness; E Brannon Morris; Vikki G Nolan; Carrie R Howell; Laura S Gilchrist; Marilyn Stovall; Cheryl L Cox; James L Klosky; Amar Gajjar; Joseph P Neglia
Journal:  Cancer       Date:  2010-06-15       Impact factor: 6.860

4.  Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy.

Authors:  Weizhen Xu; Anna Janss; Roger J Packer; Peter Phillips; Joel Goldwein; Thomas Moshang
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

5.  Final height and insulin-like growth factor-1 in children with medulloblastoma treated with growth hormone.

Authors:  Hyun Wook Chae; Young Seok Park; Dong Seok Kim; Ah Reum Kwon; Ho-Seong Kim; Duk Hee Kim
Journal:  Childs Nerv Syst       Date:  2013-06-18       Impact factor: 1.475

6.  Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.

Authors:  Yi-Peng Han; Chen-Kai Ma; Shen-Qi Wang; Atsushi Enomoto; Yang Zhao; Masahide Takahashi; Jie Ma
Journal:  J Neurooncol       Date:  2014-05-31       Impact factor: 4.130

7.  Physical functioning in pediatric survivors of childhood posterior fossa brain tumors.

Authors:  P Janine Piscione; Eric Bouffet; Donald J Mabbott; Iffat Shams; Abhaya V Kulkarni
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

8.  Atypical bilateral cerebellopontine angle medulloblastoma: differential diagnosis, immunohistochemical features and radiological presentation.

Authors:  Kelvin M Piña Batista; Sayoa Alvarez de Eulate-Beramendi; María Rico; Victor Rodrigo; Yordy E Batista Batista; Kenia Y Alvarez Reyes
Journal:  Contemp Oncol (Pozn)       Date:  2017-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.